fluoromethyl 2,2-difluoro-1-(trifluoromethyl)vinyl ether has been researched along with Hepatorenal Syndrome in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fujii, K; Fukuda, H; Kawamoto, M; Yuge, O | 1 |
1 trial(s) available for fluoromethyl 2,2-difluoro-1-(trifluoromethyl)vinyl ether and Hepatorenal Syndrome
Article | Year |
---|---|
A comparison of the effects of prolonged (>10 hour) low-flow sevoflurane, high-flow sevoflurane, and low-flow isoflurane anaesthesia on hepatorenal function in orthopaedic patients.
Topics: Adult; Anesthesia, Inhalation; Anesthetics, Inhalation; Biomarkers; Chromatography, Gas; Ethers; Female; Hepatorenal Syndrome; Humans; Hydrocarbons, Fluorinated; Isoflurane; Kidney; Kidney Function Tests; Liver; Liver Function Tests; Male; Methyl Ethers; Sevoflurane; Surgical Flaps; Time Factors | 2004 |